AbbVie (ABBV) Income from Non-Controlling Interests (2020 - 2025)
Historic Income from Non-Controlling Interests for AbbVie (ABBV) over the last 6 years, with Q3 2025 value amounting to $2.0 million.
- AbbVie's Income from Non-Controlling Interests fell 3333.33% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 3636.36%. This contributed to the annual value of $8.0 million for FY2024, which is 2000.0% down from last year.
- Latest data reveals that AbbVie reported Income from Non-Controlling Interests of $2.0 million as of Q3 2025, which was down 3333.33% from $3.0 million recorded in Q2 2025.
- AbbVie's Income from Non-Controlling Interests' 5-year high stood at $4.0 million during Q2 2022, with a 5-year trough of -$1.0 million in Q4 2022.
- In the last 5 years, AbbVie's Income from Non-Controlling Interests had a median value of $3.0 million in 2021 and averaged $2.2 million.
- Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first skyrocketed by 40000.0% in 2021, then tumbled by 20000.0% in 2022.
- AbbVie's Income from Non-Controlling Interests (Quarter) stood at $1.0 million in 2021, then plummeted by 200.0% to -$1.0 million in 2022, then surged by 300.0% to $2.0 million in 2023, then crashed by 150.0% to -$1.0 million in 2024, then surged by 300.0% to $2.0 million in 2025.
- Its Income from Non-Controlling Interests stands at $2.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.